Knee Osteoarthritis is a major clinical and economic burden to the NHS
- MSK conditions have a £10.2 billion annual health burden ~ 5% of total NHS costs53
- 8.5 million people in the UK suffer from osteoarthritis ~12.5% of the population55
- Apos® is recommended by NICE for people with knee osteoarthritis51
Apos® reduces healthcare burden, lowers resource utilisation, and leads to better outcomes and efficient use of MSK services
Surgery
Radiology
Injections
Apos® can support elective care pathways by providing an effective alternative to surgery and reducing the need for other resources like imaging and less effective treatments.
Meet Apos®
An Innovative CE-Marked and NICE recommended medical device to improve clinical outcomes and reduce spending related to knee osteoarthritis.
- 84% did not progress to TKR after 2 years54
- 83% of patients report at least a 50% reduction in pain42
- Available via NHS Supply Chain
Treating the underlying problem changes everything.
Apos® is a non-invasive medical device that is personalised to treat the cause of your specific pain by retraining your gait (how you walk) to help you move better and live better.
Redistribute:
Shift your weight away from painful areas42
Reeducate:
Retrain how you walk for long-term relief even when not wearing your Apos®42
Find out how Apos® can help your patients.
Complete the form below to be contacted by the Apos® team.
